MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1021/acsnano.6c06951

Медицинская библиотека · ACS nano · 2026

Therapeutic Reversal of PH-HFpEF via Lung Spheroid Cell Exosomes.

Cantor Halle J, Zhu Dashuai, Li Zhenhua, Hu Shiqi, Popowski Kristen D, Liu Mengrui, Li Junlang, Mullens Nate, Thompson Eric, Caddell Andrew, Bonagura John, Dinh Phuong-Uyen C, Cheng Ke

СтатьяПеревод в очереди

Аннотация

Pulmonary hypertension-associated heart failure with preserved ejection fraction (PH-HFpEF) is a prevalent and lethal cardiopulmonary syndrome without effective disease-modifying therapy. We investigated the therapeutic potential of lung spheroid cell-derived exosomes (LSC-Exos) in a murine model of PH-HFpEF induced by high-fat diet feeding. The disease phenotype was validated by echocardiography and histologic assessment. Mice with established PH-HFpEF received daily nebulized LSC-Exo for 3 weeks. Treatment significantly improved right and left ventricular structural parameters, reduced regurgitation velocity, and attenuated pulmonary vascular wall thickening compared with untreated controls. Transcriptomic profiling revealed activation of PI3K-Akt signaling in the lung and suppression of downstream mTOR signaling in the heart following LSC-Exo therapy, with marked upregulation of miR-150-5p in cardiac tissue. To define the mechanistic contribution, diseased mice were treated with miR-150-5p-enriched exosomes or exosomes containing a miR-150-5p inhibitor. miR-150-5p-loaded exosomes recapitulated the majority of functional and structural improvements and modulated mTOR pathway activity, whereas inhibition of miR-150-5p attenuated therapeutic efficacy. No safety concerns were observed. These findings demonstrate that nebulized LSC-Exo therapy ameliorates cardiopulmonary remodeling in PH-HFpEF and identify exosomal miR-150-5p as a key mediator of therapeutic benefit via regulation of PI3K-Akt-mTOR signaling. This study supports the development of inhaled exosome-based therapies for cardiopulmonary vascular disease.

Для цитирования: Cantor Halle J, Zhu Dashuai, Li Zhenhua, Hu Shiqi, Popowski Kristen D, Liu Mengrui, Li Junlang, Mullens Nate, Thompson Eric, Caddell Andrew, Bonagura John, Dinh Phuong-Uyen C, Cheng Ke. Therapeutic Reversal of PH-HFpEF via Lung Spheroid Cell Exosomes.. ACS nano. 2026. DOI: 10.1021/acsnano.6c06951.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.